Thank you for subscribing to our blog.
We’ll hit your inbox next week with our latest post.

Latest Insights and Updates Delivered to your Inbox!

Subscribe now for exciting weekly industry news!

The Impact of Generative AI in Clinical Trials
Generative AI in clinical trials, a subset of Artificial Intelligence (AI), holds promise as clinical trials not only should be flexible and adaptable but also cost-effective, catering to the diverse needs of various stakeholder groups. The intricacies of clinical trials, inherently labor-intensive, complex, and heavily regulated, make this task pa...
Top Pharma Articles of 2023: Year in review
Clinical Research Organizations (CROs) play a significant role in clinical research and in transforming healthcare. Ranging from catering to specialized niche pharmaceutical companies to expansive global pharma companies, CROs serve as the driving force behind the journey of new drugs and medical devices from conception to FDA approval. CRO’...
Managing Efficient Clinical Trials with CROs: Guide to Finding Top Clinical Research Organizations in 2024
Clinical trials present a complex landscape that demands meticulous navigation through the intricacies of protocol development, regulatory compliance, and trial management—an inherently formidable task. It is in this intricate terrain that Contract Research Organizations (CROs) assume a pivotal role, emerging as indispensable partners for sp...
Designing Efficient Clinical Trials for Rare Diseases’ Orphan Drug Development
In this exciting blog, we focus on the research and innovation in rare disease clinical trials. Navitas Life Sciences’ commitment to accelerating pharmaceutical breakthroughs globally is reflected in our extensive experience of 600+ clinical trials, expertise in 20+ therapeutic areas, and a proven track record of collaborating with biopharma...
Navitas Life Sciences Supports Efficient Clinical Trials for Advancing Treatment for HIV/AIDS
The World Health Organization states that nearly 39 million people live with HIV/AIDS globally (2022), with 630,000 people dying due to HIV related causes, necessitating the need for improved treatment and care. Navitas Life Sciences has been supporting the efficient management of clinical trials for small to large pharma and life sciences companie...
Steps to Developing Effective Patient Registries: Parkinson’s Foundation
Navitas Life Sciences will be at the Parkinson’s Foundation and Parkinson Study Group Annual Conference 2023 Patient registries are vital tools, orchestrating the collection of clinical data to advance the understanding and treatment of various conditions. We are delighted to be sponsoring the upcoming Future of Parkinson’s Disease: I...
Navitas Life Sciences’ Clinical Data Services: Showcasing at CPHI India 2023
Navitas Life Sciences boasts extensive experience in Clinical Data Services, covering a spectrum of crucial aspects including Data Management, Biostatistics & Programming, Data Standardization, Medical Writing, and Submissions. We are dedicated to delivering high-quality clinical trial data management while adhering to rigorous regulatory stand...
World Diabetes Day 2023: Supporting Diabetes Research through State-of-the-Art Euglycemic Clamp Studies
As we join the World Health Organization in observing the World Diabetes Day on November 14th, 2023, the global community faces an escalating diabetes crisis, demanding revolutionary advancements in therapeutic solutions. In this spirit, Navitas Life Sciences offers strategic partnerships to pharmaceutical companies, both large and small, in their ...
Leading Expert Insights on Drug Development and Immunology
Dr Narendra Chirmule Director of Biological Sciences at Symphony Technology In this exciting blog, we have the privilege of hearing from a seasoned expert, Dr Narendra Chirmule, PhD who has dedicated decades to advancing our understanding of immunology and pushing the boundaries of drug development. Dr Chirmule is a Director of Biological Sciences ...
Placing Patient Safety First: Preventing side effects and interactions with Medication Analysis
In our latest blog, Dr Philipp Hofmann, Director - Pharmacovigilance & QPPV, explores the significance of medication analysis, particularly for older patients in Germany. Offering a professional assessment, this analysis addresses crucial questions regarding potential adverse drug reactions and interactions. Dr Hofmann provides a comprehensive ...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us